The Oncology Institute, Inc. (TOI)
NASDAQ: TOI · Real-Time Price · USD
3.440
+0.110 (3.30%)
At close: Apr 28, 2026, 4:00 PM EDT
3.430
-0.010 (-0.29%)
After-hours: Apr 28, 2026, 5:26 PM EDT
The Oncology Institute Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for The Oncology Institute stock have an average target of 6.67, with a low estimate of 5.00 and a high estimate of 8.00. The average target predicts an increase of 93.90% from the current stock price of 3.44.
Analyst Consensus: Strong Buy
* Price targets were last updated on Mar 13, 2026.
Analyst Ratings
The average analyst rating for The Oncology Institute stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| B. Riley Securities | B. Riley Securities | Strong Buy Maintains $6 → $8 | Strong Buy | Maintains | $6 → $8 | +132.56% | Mar 13, 2026 |
| Needham | Needham | Strong Buy Reiterates $5 | Strong Buy | Reiterates | $5 | +45.35% | Mar 13, 2026 |
| Needham | Needham | Strong Buy Reiterates $5 | Strong Buy | Reiterates | $5 | +45.35% | Mar 9, 2026 |
| BTIG | BTIG | Strong Buy Reiterates $7 | Strong Buy | Reiterates | $7 | +103.49% | Mar 9, 2026 |
| Needham | Needham | Strong Buy Initiates $5 | Strong Buy | Initiates | $5 | +45.35% | Nov 25, 2025 |
Financial Forecast
Revenue This Year
654.31M
from 502.73M
Increased by 30.15%
Revenue Next Year
822.95M
from 654.31M
Increased by 25.77%
EPS This Year
-0.28
from -0.54
EPS Next Year
-0.08
from -0.28
Revenue Forecast
| Revenue | 2026 | 2027 |
|---|---|---|
| High | 693.2M | 855.5M |
| Avg | 654.3M | 823.0M |
| Low | 627.3M | 798.5M |
Revenue Growth
| Revenue Growth | 2026 | 2027 |
|---|---|---|
| High | 37.9% | 30.8% |
| Avg | 30.2% | 25.8% |
| Low | 24.8% | 22.0% |
EPS Forecast
| EPS | 2026 | 2027 |
|---|---|---|
| High | -0.21 | -0.08 |
| Avg | -0.28 | -0.08 |
| Low | -0.43 | -0.08 |
EPS Growth
| EPS Growth | 2026 | 2027 |
|---|---|---|
| High | - | - |
| Avg | - | - |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.